ensun logo
Locations
Company type
Result types
Industries
Employees
Founding year
Cambridge Respiratory Innovations Logo

Cambridge Respiratory Innovations

TidalSense, formerly Cambridge Respiratory Innovations, is a venture-backed respiratory technology company founded in 2013 and headquartered in Cambridge UK. TidalSense is partnering across the care spectrum to drive a fundamental shift in respiratory care management. Our technologies are built on the foundation of our novel patented sensor technology, embedded within N-Tidal, which provides unprecedented insight into lung physiology through high accuracy, rapid sampled CO2, unlike anything seen before in clinical medicine. COPD and Asthma affect nearly 10% of Earth’s population, with COPD now listed as the 3rd leading cause of death worldwide. Patented, industry leading sensor that’s 10 years in the making, with clinical evidence that proves it's changing how we understand respiratory health.

Quick overview

Cambridge, United Kingdom

Founded in 2013

11-50 Employees

Additional information

Working industry

Medical

Type of company

-

Ownership structure

Privately Held

Locations

1 Headquarter

Specialised areas

Medical Device

ESG score estimation

An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself

Country:

United Kingdom


Overall risk estimation:

Very low


ESG country scores

The ESG Data of countries are based on public sources

Environment

A

Grade (A-E)

View details

Social

A

Grade (A-E)

View details

Governance

A

Grade (A-E)

View details

Headquarter of Cambridge Respiratory Innovations

Cambridge Respiratory Innovations operates in 1 country around the world

City: Cambridge

State: England

Country: United Kingdom

Locations of Cambridge Respiratory Innovations

Get an overview of the locations of Cambridge Respiratory Innovations

Location

Country

State

City

Headquarter

United Kingdom

England

Cambridge

Frequently asked questions (FAQ) about Cambridge Respiratory Innovations

Some frequent questions that have been asked about Cambridge Respiratory Innovations

The company headquarter of Cambridge Respiratory Innovations is located in Cambridge, England, United Kingdom. It's worth noting, that the company may have more locations

As of the latest available information Cambridge Respiratory Innovations has around 11-50 employees worldwide.

Cambridge Respiratory Innovations was founded in 2013

The company Cambridge Respiratory Innovations has it's main focus in the industries of Medical

Competitors of Cambridge Respiratory Innovations

Check out some interesting alternative companies to Cambridge Respiratory Innovations

NanoVation's Logo

NanoVation

-

1-10 Employees

2014

We provide a reliable solution for monitoring of various chronic respiratory diseases, including COPD and asthma. Innovative solutions for remote monitoring and disease management of lung diseases and chronic respiratory conditions. An innovative nanosensor-based wearable device that enables spot non-invasive monitoring of critical respiratory parameters derived from patients' tidal (normal) breathing, canceling the need for forced expirations.

Tidal Medical's Logo

Tidal Medical

Old Toronto, Canada

11-50 Employees

-

Tidal Medical is a medical device and digital health company determined to redefine congestive heart failure management by offering unparalleled access to high-quality outpatient care from the home setting.

Strados Labs's Logo

Strados Labs

Philadelphia, United States

11-50 Employees

2016

The RESP Biosensor offers clinical trialists a way to objectively measure symptoms associated with treatment response for indications such as chronic cough, IPF, and Asthma. Our technology offers clinical teams an enhanced approach to monitoring at-risk patients in inpatient settings such as hospitals and skilled nursing facilities. Effectively monitoring respiratory patients at home is a challenge for clinicians, with 30-day readmissions for COPD often exceeding 20%². Predicting and preventing hospital readmission for exacerbation of COPD, 2020. Strados Labs founder, Nick Delmonico, is a patient who has spent time in the ER and the ICU due to asthma and respiratory illness like RSV. Schedule time with our respiratory experts to learn how we can help.

My AirGo's Logo

My AirGo

Milan, Italy

1-10 Employees

2014

We are focused on confidently bringing physicians clinical data, precise lung volumetric analysis, and technology to provide a complete and accurate 24/7 picture of health. We are guided by science, clinical data and unique partnerships with world renowned institutions and leading respiratory physicians in North America and Europe. We are working with leading respiratory physicians to monitor and analyse real patient data. We intend to help hospital staff to be more productive. Thanks to our research with some of the most respected respiratory scientists, we are delivering deeply insightful solutions to gather more powerful patient data and analytical tools for assessing health - in the hospital and at home. Expertise includes large-scale internet infrastructure, complex fault-tolerant scalable architectures, and cloud computing architectures. Expertise in product design, UX & UI design, product development, software ecosystem, apps & cloud services, vertical application coordination, medical testing & usability analysis. Airgo is the first 24/7 non-invasive wireless respiratory platform that measures every breath directly, with live analytics, automated scoring, and predictive alerts to allow physicians to monitor your health with previously unavailable precision.

PMD Solutions's Logo

PMD Solutions

Cork, Ireland

1-10 Employees

2011

PMD Solutions was founded by Myles Murray to void the fundamental clinical need to measure patients breathing rates, which if amiss, is a significant indicator of an adverse event. PMD Solutions as a company aims to lead the way in terms of innovative products having patients motivating everything we do. By achieving this we will always deliver the best results we possibly can. We define and measure excellence and success in quality of patient care and our products. Medtech – awarded PMD solutions as the Top Respiratory Device providers 2021. PMD Solutions selected as innovative respiratory device leader to join the NHS Innovation Accelerator Programme. PMD Solutions is founded and begins developing its first prototype. RespiraSense transforms the measurement of a patient’s Respiratory Rate with continuous, innovative, technology monitoring – improving the measurement and identification of deterioration, in a real-time manner to help save lives.

Neosense Technologies's Logo

Neosense Technologies

Stockholm, Sweden

1-10 Employees

2014

We are an innovative start-up company supplying intensive care units for critically ill patients with continuous oxygen monitoring systems for improved control and safety.Neosense is a Swedish medical company based in Stockholm. Neosense Technologies has developed a world unique sensor for real-time measurement of blood oxygenation. Neosense offer solutions to healthcare providers worldwide with outstanding capability for real time measurement, monitoring, and control of blood oxygenation for critically ill patients.